At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 237 enrolled
Drug / intervention
Fentanyldrug
Likely dose
Fentanyl 12.5 microgramfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy, Safety and Quality of Life Outcome of Fentanyl Transdermal Patch (Durogesic-D-Trans) Among Filipino Patients With Osteoarthritis and Chronic Low Back Pain
In Brief
A Phase 4 clinical trial evaluating Fentanyl for Osteoarthritis and Low Back Pain. Completed, enrolled 237 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the efficacy and safety of fentanyl among Filipino participants with osteoarthritis (disorder which is seen mostly in older persons in which the joints become painful and stiff) and chronic (lasting a long time) low back pain.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsOsteoarthritis, Low Back Pain
CountriesPhilippines
Collaborators--
Timeline
Phase 4CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJan 2009
Primary CompletionSep 2009
First PostedFeb 2013
TodayJul 2026
First PostedFeb 21, 2013
Enrollment StartJan 1, 2009
Primary CompletionSep 1, 2009
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 13.4 years ago
Interventions
Fentanyldrug
Fentanyl transdermal patches releasing 12.5 microgram of fentanyl will be applied for 3 days. The patches will be replaced every 3 days (Day 3, 7 and 10).